Palvella Therapeutics (PVLA) Current Leases (2021 - 2026)

Palvella Therapeutics (PVLA) has reported Current Leases for 5 consecutive years, with $209000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Leases changed N/A year-over-year to $209000.0; the TTM figure through Mar 2026 stood at $209000.0 (changed N/A YoY), while the FY2025 annual figure was $202000.0, changed N/A from the prior year.
• Current Leases climbed to $209000.0 in Q1 2026 per PVLA's latest filing, from $202000.0 in the prior quarter.
• Across five years, Current Leases topped out at $12.3 million in Q3 2023 and bottomed at $202000.0 in Q4 2025.
• Historically, Current Leases has averaged $2.3 million across 4 years, with a median of $859000.0 in 2022.
• Annual changes were most pronounced in 2022 — Current Leases declined 18.11% — and 2023, when it surged 1388.14%.
• Palvella Therapeutics' Current Leases stood at $859000.0 in 2022, then soared by 1330.97% to $12.3 million in 2023, then slumped by 98.36% to $202000.0 in 2025, then climbed by 3.47% to $209000.0 in 2026.
• Business Quant data shows PVLA's Current Leases at $209000.0 in Q1 2026, $202000.0 in Q4 2025, and $12.3 million in Q3 2023.